Billings veterinary clinic conducts city’s first dog stem cell therapy treatment

Thor, an athletic 7-year-old Catahoula leopard hound, lay on a table at the Animal Clinic of Billings, panting lightly while staffers put small bags over his feet and temperature-controlled packs on his chest before the anesthesia kicked in.

Not long after he went under, those same staff members carried Thor to an operating table where his owner, Dr. Bobbi Jo Massic, who is also a veterinarian at the clinic, made a small incision in his abdomen, the first step in a cutting-edge process designed to help the alleviate the dogs hip dysplasia and arthritis.

By the end of Tuesday, Thor became the very first patient in the clinics brand new animal stem cell therapy program.

This is a very exciting day, said Dr. Bryna Felchle, another vet at the clinic who will help spearhead the program. Were launching our very first stem cell therapy right here.

The process is widespread across the United States, but Felchle is just the second vet in Montana certified to perform the procedure and the only one in the eastern half of the state.

Generally, it involves removing fatty tissue from an animal, separating the stem cells from that tissue, activating the cells and then injecting or applying them back into the animal to promote healing or tissue growth.

The stem cells which differentiate and adapt into needed cells and tissues help to treat arthritis, hip dysplasia, ligament and cartilage injuries and other degenerative diseases.

Massic said Thor is a very active dog. Several years ago, he tore an anterior cruciate ligament, for which he underwent three surgeries and has a metal plate and three screws in one of his legs, along with the arthritis and dysplasia.

He has a lot of his active life ahead of him, she said. Were hoping that we can get him back to that mobility he had before.

She also said it could cut down on healing time, since the surgery requires fairly small incisions and a simple injection of the cells later.

Read more:
Billings veterinary clinic conducts city's first dog stem cell therapy treatment

Stop stem cell therapy – Doctor

Manila, Philippines -- If she would have her way, Dr. Marita V.T. Reyes, Co-Chairperson of the Philippine Health Research Ethics Board (PHREB), yesterday said she would put a stop to the medical procedure of stem cell therapy.

Reyes delivered a paper yesterday on the topic, "Ethical Consideration In Stem Cell-based Therapy and Research-Poor Countries," on the last day of the 35th Annual Scientific Meeting of the Department of Science and Technology-National Academy of Science and Technology (DOST-NAST) at the historic landmark Manila Hotel.

Reyes acknowledged that there is a "standard" stem cell therapy treatment involving "hematopoietic disorders," such as "leukemia and lymphomas," through "bone marrow or cord blood transplant."

She, however, emphasized that this cannot be said yet in the cases of diseases of the heart, eyes, diabetes, stroke, spinal cord injury, Parkinson's, Alzheimer's, Lou Gehrig's (ALS), multiple sclerosis, cancer, and cartilage repair.

Stem cell therapy for these diseases, she stressed, should be stopped.

"If I have the power, I will say, 'stop this in the meantime, until the Food and Drug Administration (FDA) has come up with a quality assurance. Until the FDA is able to say that what you say is there, is there, we have no way of protecting our people," said Reyes, when asked about the ethics board's possible advice.

"So, as far as I am concerned, I would like the stem cell therapy, meaning for people who are saying they are using stem cell therapy, to stop, until we have set up very clear quality assurance (system)," the PHREB official said.

Stem cell therapy discussions resulted from the reported death of three Filipino politicians, and the complaint of a government official, after allegedly subjecting themselves from the controversial medical procedure.

Dr. Francisco Chung, Jr., of the Makati Medical Center (MMC), on the other hand, conceded that there are many stem cell procedures that are "experimental in nature."

"What we have approved clinically is bone marrow transplantation," he said, citing the approval of the United States Food and Drug Administration (USFDA).

Read more:
Stop stem cell therapy – Doctor

53rd ICAAC: Media registration now open

Public release date: 10-Jul-2013 [ | E-mail | Share ]

Contact: Jim Sliwa jsliwa@asmusa.org 202-942-9297 American Society for Microbiology

News media registration for the annual infectious diseases meeting of the American Society for Microbiology (ASM) is now open. The 53rd Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) will be held September 10-13, 2013 at the Colorado Convention Center in Denver, Colorado.

Known as the preeminent world meeting for presenting new information on clinical and basic research in infectious diseases and anti-infective therapy, ICAAC has also traditionally served as a forum for the introduction of new antimicrobial agents. It is the largest infectious disease meeting held in the United States.

The opening keynote session will focus on the future of antibiotic therapy, urging infectious disease professionals to rethink the "one diseaseone pathogenone drug," paradigm currently used to treat disease in favor of more multifaceted and integrated therapeutic interventions aimed at restoring the health of all sick compartments involved in infection.

This year's meeting will also feature a special address by Trevor Mundel of the Bill and Melinda Gates Foundation who will speak on the importance of innovation to address infectious diseases in the developing world. Dr. Mundel will address current vaccine discovery programs, strategies for the future, neglected diseases and plans for accelerating research and development efforts for low resource settings through new partnerships and programs.

The ASM Office of Communications will host a full-service press room with Internet access, telephones, computers, photocopy and fax machines, and refreshments. Streaming audio and video of daily press conferences will be available over the Internet for reporters covering from a distance. Programs and abstracts, as well as an embargoed online press kit featuring tipsheets, lay-summaries of selected presentations and the press conference schedule will be available in advance of the meeting. For media registration and housing please go to http://bit.ly/53icaacpr.

###

The American Society for Microbiology, headquartered in Washington, D.C., is the largest single life science association, with over 39,000 members worldwide. Its members work in educational, research, industrial, and government settings on issues such as the environment, the prevention and treatment of infectious diseases, laboratory and diagnostic medicine, and food and water safety. The ASM's mission is to gain a better understanding of basic life processes and to promote the application of this knowledge for improved health and economic and environmental well-being.

Read more here:
53rd ICAAC: Media registration now open